CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy
Source abstract
Abstract
Translation of nanoparticles (NPs) into clinical practice has been limited by toxic effects induced by nonspecific accumulation of NPs in healthy organs after systemic administration. The ideal NPs should accumulate in the target site, carry out their function, and then ultimately be eliminated from the body. Here, we show a single-compartment, multifunctional ultrasmall copper sulfide nanodot (CuS ND) that is rapidly cleared from the body. These CuS NDs have a hydrodynamic diameter of <6 nm, can efficiently absorb near-infrared light for photothermal ablation therapy, and stably incorporate the copper-64 radioisotope for noninvasive positron emission tomography (PET). Importantly, ∼95% of CuS NDs are excreted intact through the renal-urinary system within 24 h with minimal retention in the liver and the spleen. The ultrasmall CuS NDs accumulate in 4T1 tumors in Balb/c mice, as monitored by PET imaging, and mediate tumor ablation when combined with near-infrared light irradiation. As a first example of PET-visible, renal-clearable inorganic nanomaterials with peak absorption in the near-infrared region, CuS NDs represent a robust platform for cancer imaging and therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Quantum Dots Synthesis And Properties · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Sciences, Texas Southern University, Houston, Texas 77004, United States
Funding
John S. Dunn Foundation · National Cancer Institute
References (49)
Show source-provided references
1. Service R. F. · Science · 2005 · 310 · 113210.1126/science.310.5751.1132 ↗
2. Davis M. E. · Nat. Rev. Drug Discovery · 2008 · 7 · 77110.1038/nrd2614 ↗
3. Thakor A. S. · Ca-Cancer J. Clin. · 2013 · 63 · 39510.3322/caac.21199 ↗
4. Li C. · Nat. Mater. · 2014 · 13 · 11010.1038/nmat3877 ↗
5. Liu J. B. · Mater. Today · 2013 · 16 · 47710.1016/j.mattod.2013.11.003 ↗
6. Scheinberg D. A. · Nat. Rev. Clin. Oncol. · 2010 · 7 · 26610.1038/nrclinonc.2010.38 ↗
7. Melancon M. P. · Acc. Chem. Res. · 2011 · 44 · 94710.1021/ar200022e ↗
8. Shanmugam V. · Chem. Soc. Rev. · 2014 · 43 · 625410.1039/C4CS00011K ↗
9. Liang C. · Chem. Rev. · 2014 · 114 · 1086910.1021/cr400532z ↗
10. Chu K. F. · Nat. Rev. Cancer · 2014 · 14 · 19910.1038/nrc3672 ↗
11. Hirsch L. R. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 1354910.1073/pnas.2232479100 ↗
12. Melancon M. P. · Biomaterials · 2011 · 32 · 760010.1016/j.biomaterials.2011.06.039 ↗
13. Huang X. · J. Am. Chem. Soc. · 2006 · 128 · 211510.1021/ja057254a ↗
14. Huang X. · Methods Mol. Biol. · 2010 · 624 · 34310.1007/978-1-60761-609-2_23 ↗
15. Chen J. Y. · Nano Lett. · 2007 · 7 · 131810.1021/nl070345g ↗
16. Chen J. Y. · Small · 2010 · 6 · 81110.1002/smll.200902216 ↗
17. You J. · Cancer Res. · 2012 · 72 · 477710.1158/0008-5472.CAN-12-1003 ↗
18. Zhao N. · Small · 2013 · 9 · 347710.1002/smll.201202694 ↗
19. Chakravarty P. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 869710.1073/pnas.0803557105 ↗
20. Moon H. K. · ACS Nano · 2009 · 3 · 370710.1021/nn900904h ↗
21. Yang K. · Nano Lett. · 2010 · 10 · 331810.1021/nl100996u ↗
22. Robinson J. T. · J. Am. Chem. Soc. · 2011 · 133 · 682510.1021/ja2010175 ↗
23. Zhou M. · J. Am. Chem. Soc. · 2010 · 132 · 1535110.1021/ja106855m ↗
24. Ramadan S. · Small · 2012 · 8 · 314310.1002/smll.201200783 ↗
25. Hessel C. M. · Nano Lett. · 2011 · 11 · 256010.1021/nl201400z ↗
26. Tian Q. W. · Adv. Mater. · 2011 · 23 · 354210.1002/adma.201101295 ↗
27. Zhou M. · Nanoscale · 2014 · 6 · 1522810.1039/C4NR05386A ↗
28. Schipper M. L. · Small · 2009 · 5 · 12610.1002/smll.200800003 ↗
29. Jokerst J. V. · Nanomedicine · 2011 · 6 · 71510.2217/nnm.11.19 ↗
30. You J. · Part. Fibre Toxicol. · 2014 · 11 · 2610.1186/1743-8977-11-26 ↗
31. Liu Z. · Nat. Nanotechnol. · 2007 · 2 · 4710.1038/nnano.2006.170 ↗
32. Yang S. T. · J. Phys. Chem. C · 2007 · 111 · 1776110.1021/jp070712c ↗
33. Longmire M. · Nanomedicine · 2008 · 3 · 70310.2217/17435889.3.5.703 ↗
34. Choi H. S. · Nat. Biotechnol. · 2013 · 31 · 14810.1038/nbt.2468 ↗
35. Choi H. S. · Nat. Nanotechnol. · 2010 · 5 · 4210.1038/nnano.2009.314 ↗
36. Choi H. S. · Nano Lett. · 2009 · 9 · 235410.1021/nl900872r ↗
37. Choi H. S. · Nat. Biotechnol. · 2007 · 25 · 116510.1038/nbt1340 ↗
38. Zhou Z. J. · ACS Nano · 2013 · 7 · 328710.1021/nn305991e ↗
39. Bonitatibus P. J. · ACS Nano · 2012 · 6 · 665010.1021/nn300928g ↗
40. Garcia K. P. · Small · 2014 · 10 · 251610.1002/smll.201303540 ↗
41. Liu J. B. · Angew. Chem., Int. Ed. · 2013 · 52 · 1257210.1002/anie.201304465 ↗
42. Zhou C. · Angew. Chem., Int. Ed. · 2011 · 50 · 316810.1002/anie.201007321 ↗
43. Liu J. B. · J. Am. Chem. Soc. · 2013 · 135 · 497810.1021/ja401612x ↗
44. Semmler-Behnke M. · Small · 2008 · 4 · 210810.1002/smll.200800922 ↗
45. Namekawa K. · ASAIO J. · 2009 · 55 · 23610.1097/MAT.0b013e3181984229 ↗
46. Wu Z. Q. · Langmuir · 2009 · 25 · 290010.1021/la8037523 ↗
47. Qin H. · Polym. Adv. Technol. · 2014 · 25 · 85110.1002/pat.3316 ↗
48. Scheinin H. · Ann. Med. · 1999 · 31 · 43010.3109/07853899908998800 ↗
49. Ametamey S. M. · Chem. Rev. · 2008 · 108 · 150110.1021/cr0782426 ↗